Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.
Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.
Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.
In Setback For Generics, Court Overturns FDA.
Advisors Suggest Consortia For Lung Cancer Research.
Young Elected ACS President, Von eschenback Pres.-Elect.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?